share_log
Benzinga ·  Jul 19 08:36
60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment